The Effect of Commonly Used Fixed-Dose Single Pill Combinations of Renin-Angiotensin-System Blockers and Calcium

Angelos Liontos1, Dimitrios Biros1, Christos Papagiannopoulos2

  • 1First Department of Internal Medicine, Faculty of Medicine, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece.

Maedica
|December 21, 2022
PubMed

Insights

Telmisartan plus amlodipine combination therapy significantly improved insulin resistance in hypertensive patients with impaired fasting glucose. Other drug combinations showed neutral or unfavorable effects on insulin sensitivity.

Area of Science:

  • Cardiovascular Pharmacology
  • Metabolic Syndrome Research
  • Hypertension Management

Background:

  • Investigating the impact of antihypertensive drugs on glucose metabolism and insulin resistance.
  • Renin-angiotensin system (RAS) blockers may benefit glucose metabolism, while calcium channel blockers (CCBs) have neutral effects.
  • Differential effects on glycemic indices exist within antihypertensive drug classes.

Discussion:

  • Comparing fixed-dose single pill combinations of RAS blockers and CCBs for their effects on insulin resistance.
  • Evaluating homeostatic model assessment for insulin resistance (HOMA-IR) changes in hypertensive patients with impaired fasting glucose.
  • Assessing the impact of valsartan/amlodipine, delapril/manidipine, and telmisartan/amlodipine on insulin resistance.

Key Insights:

  • Telmisartan/amlodipine combination therapy significantly reduced HOMA-IR by 22.55% (p <0.01).
  • Valsartan/amlodipine showed a slight increase in HOMA-IR (1.4%, p = 0.57), while delapril/manidipine showed a 12.65% increase (p = 0.072).
  • Significant differences in HOMA-IR changes were observed between telmisartan/amlodipine and the other two combinations.

Outlook:

  • Telmisartan/amlodipine combination demonstrates a favorable effect on insulin resistance compared to valsartan/amlodipine and delapril/manidipine.
  • Further research into the specific mechanisms underlying these differential metabolic effects is warranted.
  • Clinical implications for managing hypertension and metabolic disturbances in co-morbid patients.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
736
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
482
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
809
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
647
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
754
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
28